Innovation Theater.
Why most corporate innovation doesn't actually innovate.

You've seen this before

The dedicated floor with bean bags and whiteboards. The quarterly ideation sprint. The venture fund that backs ideas nobody tracks past the pilot. The Chief Innovation Officer who reports to the CFO.

We see it in almost every large organisation we work with. The infrastructure of innovation is everywhere. The outcomes are nowhere. Capgemini's research puts the failure rate for corporate innovation labs at 80 to 90 percent. That number is striking, but the real question is what "failure" means in this context. It means the lab made zero measurable contribution to the business model. Not the process. The business model.

If this project succeeds completely, what is fundamentally different about how we create or capture value? If the answer is "not much," you're running theater.

Coca-Cola built Founders, an accelerator designed to bring external innovation into the business. They shut it down. The company redirected resources back to core beverage innovation because the accelerator, for all its visibility, wasn't changing how Coca-Cola actually competed. That's a company with the resources and the talent to make it work. They still couldn't bridge the gap between performing innovation and doing it.

Why smart people build things that don't matter

Innovation theater isn't cynical. That's what makes it so persistent. The people inside it are usually talented, motivated, and working hard. The system around them makes the theater rational.

Executives face genuine pressure to demonstrate innovation. Boards ask about it. Analysts write about it. Competitors announce it. So leaders create visible signals of innovation activity without taking the actual risk that real innovation requires. A lab is visible. A hackathon is visible. A pilot that's designed to succeed on its own terms, with a graceful exit built in, is visible. And none of them demand the structural commitment that would make them dangerous to the status quo.

PwC's Global Innovation 1000 study found something that should unsettle every CFO who's ever signed off on an innovation budget: there's no long-term correlation between how much a company spends on innovation and its financial performance. What matters is how they use it, the quality of their decisions, and whether the work connects to something customers actually want. The budget is the easiest part. The hard part is the willingness to let something real happen.

Four things that separate theater from building

The window closes while the lab runs sprints

The visible cost of innovation theater is the budget. Enterprises lost over $104 million in 2024 on underused technology and low adoption alone. But that figure understates the real damage.

The real cost is the window. Every year spent running theater is a year the market moves. Assets strand. Competitors with real conviction build real positions. The threshold you needed to cross shifts further out. We keep seeing this: the original moment, the window when a venture could have been built cheaply and with genuine advantage, closed while the lab was still running ideation sprints.

Model what the competitive landscape looks like in 24 months if nothing real changes. What assets strand? What market position erodes? That number is the one leadership needs to see.

Bill Gross's study of 200 ventures found timing accounts for 42 percent of the difference between success and failure. Forty-two percent. And corporate innovation theater is a timing problem. The organisation spends years building the apparatus of innovation. The market doesn't wait for the apparatus to start producing.

We worked with one energy company that spent three years running an innovation lab. Quarterly showcases, a full-time team of eight, external partnerships with two accelerators. When we asked what the lab had changed about the core business, the answer was an uncomfortable silence. The market they'd been studying had been captured by a competitor who entered 18 months earlier with a smaller team and a specific conviction about grid-edge services. The lab had ideas. The competitor had a venture.

What breaks the pattern

A real decision. One person, usually someone with genuine authority, decides to do something that could fail visibly. A pilot with a graceful exit built in is theater. A bet with real stakes, where the organisation learns something regardless of the outcome, is building.

That moment changes the energy of every room it touches. We've been in the meetings before it happens and after. Before: polite, consensus-seeking, optimising for activity metrics. After: contested, specific, focused on what the venture needs to learn in the next 90 days.

The GSSN data tells the structural version of this story. Studio-backed ventures, where conviction is concentrated and governance is light, secure seed funding at 84 percent versus 42 percent for traditional approaches. They reach Series A in 25 months versus 56. The difference isn't talent or budget. It's the willingness to concentrate accountability and move before the picture is complete.

The 83-to-3 gap, where 83 percent of companies call innovation a priority and 3 percent feel ready to deliver, isn't a capability gap. It's a courage gap. The capability exists. What's missing is the structural decision to stop performing and start building, with all the discomfort that entails.